{
    "nctId": "NCT02284737",
    "officialTitle": "A Prospective, Multi-center, Randomized Control Trial to Investigate the Efficacy of Pulmonary Artery Denervation to Improved Functional Capacity and Hemodynamics in Patients With Pulmonary Artery Hypertension",
    "inclusionCriteria": "* Provision of informed consent prior to any study specific procedures;\n* Men and women 18 years and older;\n* Group I PAH, defined as a mPAP\u226525mmHg, PCWP\\<15mmHg and PVR\\[The PVR =(mPAP-PCWP)/CO\\]\\>3.0 Woods unit.\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "General exclusion criteria:\n\n* Pregnancy and breast feeding mother;\n* Estimated life expectancy \\<12 months;\n* Scheduled major surgery in the next 6 months;\n* Inability to follow the protocol and comply with follow-up requirements or any other reason that the investigator feels would place the patient at increased risk;\n* Previous enrolment in this study or treatment with an investigational drug or device under another study protocol in the past 30 days.\n\nProcedural exclusion criteria:\n\n* WHO group II, III, IV, V PH\n* Severe Renal dysfunction (Ccr\\<30 ml/min)\n* Blood platelet count\\<100,000/L\n* Expected life span\\<6-month\n* Systematical inflammation\n* Malignant cancer(s)\n* Tricuspid valve stenosis, Supra-pulmonary valve stenosis\n* Allergic to studied drugs or metal materials."
}